Literature DB >> 7085913

Systemic mastocytosis, myelofibrosis and portal hypertension.

A H Sawers, J Davson, J Braganza, C G Geary.   

Abstract

A case of systemic mastocytosis is described in which the finding on initial presentation was hepatosplenomegaly. No dermatological abnormality was present, and the bone marrow histology originally caused some confusion with primary myelofibrosis. The clinical course and the importance of distinguishing between these two diseases is discussed. The dermatological manifestation of systemic mastocytosis, in the form of urticaria pigmentosa, is well recognised, and alerts the physician to the underlying disease. In the absence of cutaneous signs, however, the diagnosis is less obvious. The case reported had predominantly marrow and splenic involvement by the disease process, giving rise to portal hypertension, and illustrates the problems of diagnosis which can arise.

Entities:  

Mesh:

Year:  1982        PMID: 7085913      PMCID: PMC497735          DOI: 10.1136/jcp.35.6.617

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  THE MASTOCYTOSIS SYNDROME: CLINICAL AND BIOLOGICAL STUDIES.

Authors:  D J DEMIS
Journal:  Ann Intern Med       Date:  1963-08       Impact factor: 25.391

2.  Mast cells and myelofibrosis.

Authors:  W C Udoji; S A Razavi
Journal:  Am J Clin Pathol       Date:  1975-02       Impact factor: 2.493

Review 3.  The spectrum of myeloproliferative disorders.

Authors:  H S Gilbert
Journal:  Med Clin North Am       Date:  1973-03       Impact factor: 5.456

4.  Portal hypertension associated with systemic mastocytosis and splenomegaly.

Authors:  S Grundfest; A M Cooperman; R Ferguson; S Benjamin
Journal:  Gastroenterology       Date:  1980-02       Impact factor: 22.682

5.  Portal hypertension in systemic mastocytosis.

Authors:  J P Capron; D Lebrec; C Degott; D Chivrac; B Coevoet; J Delobel
Journal:  Gastroenterology       Date:  1978-03       Impact factor: 22.682

6.  HEPARIN ENHANCEMENT OF FACTORS STIMULATING BONE RESORPTION IN TISSUE CULTURE.

Authors:  P GOLDHABER
Journal:  Science       Date:  1965-01-22       Impact factor: 47.728

7.  Eosinophilia in systemic mastocytosis.

Authors:  L T Yam; C F Yam; C Y Li
Journal:  Am J Clin Pathol       Date:  1980-01       Impact factor: 2.493

8.  The formation of collagen fibers by the action of heparin on soluble collagen: an electron microscope study.

Authors:  T G MORRIONE
Journal:  J Exp Med       Date:  1952-08       Impact factor: 14.307

  8 in total
  3 in total

1.  Portal hypertension and ascites in systemic mastocytosis.

Authors:  M N Narayanan; J A Liu Yin; S Azzawi; T W Warnes; W P Turck
Journal:  Postgrad Med J       Date:  1989-06       Impact factor: 2.401

2.  A fatal case of portal hypertension complicating systemic mastocytosis in an adolescent.

Authors:  H S Fonga-Djimi; F Gottrand; M Bonnevalle; J P Farriaux
Journal:  Eur J Pediatr       Date:  1995-10       Impact factor: 3.183

3.  Systemic mastocytosis: case report and literature review.

Authors:  A H Peterson
Journal:  J Natl Med Assoc       Date:  1984-05       Impact factor: 1.798

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.